FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136153275> ?p ?o ?g. }

• W3136153275 endingPage "269" @default.
• W3136153275 startingPage "269" @default.
• W3136153275 abstract "Tumor antigen-specific redirection of cytotoxic T cells (CTLs) or natural killer (NK) cells including chimeric antigen receptor (CAR-) and T cell receptor (TCR-) cell therapy is currently being evaluated in different tumor entities including melanoma. Expression of melanoma-specific antigen recognized by the respective CAR or TCR directly or presented by HLA molecules is an indispensable prerequisite for this innovative therapy. In this study, we investigated in 168 FFPE tumor specimens of patients with stage I-IV melanoma the protein expression of HER2, TRP2, ABCB5, gp100, p53, and GD2 by immunohistochemistry (IHC). These results were correlated with clinical parameters. Membrane expression of HER2 and GD2 was also investigated in ten melanoma cell lines by flow cytometry for which corresponding tumors were analyzed by IHC. Our results demonstrated that gp100 was the most frequently overexpressed protein (61%), followed by TRP2 (50%), GD2 (38%), p53 (37%), ABCB5 (17%), and HER2 (3%). TRP2 expression was higher in primary tumors compared to metastases (p = 0.005). Accordingly, TRP2 and ABCB5 expression was significantly associated with lower tumor thickness of the primary (p = 0.013 and p = 0.025). There was no association between protein expression levels and survival in advanced melanoma patients. Flow cytometric analysis revealed abundant surface expression of GD2 and HER2 in all melanoma cell lines. The discordant HER2 expression in situ and in vitro suggests a tissue culture associated induction. In summary, our data support the use of gp100 and GD2 as a potential target for developing engineered TCR- or CAR-cell therapies, respectively, against melanoma." @default.
• W3136153275 created "2021-03-29" @default.
• W3136153275 creator A5002843682 @default.
• W3136153275 creator A5006080186 @default.
• W3136153275 creator A5040122370 @default.
• W3136153275 creator A5044921528 @default.
• W3136153275 creator A5053549188 @default.
• W3136153275 creator A5059562009 @default.
• W3136153275 creator A5067045121 @default.
• W3136153275 creator A5067776208 @default.
• W3136153275 creator A5088848441 @default.
• W3136153275 date "2021-03-24" @default.
• W3136153275 modified "2023-10-06" @default.
• W3136153275 title "Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells" @default.
• W3136153275 cites W187898767 @default.
• W3136153275 cites W1951179504 @default.
• W3136153275 cites W1964741989 @default.
• W3136153275 cites W1978833687 @default.
• W3136153275 cites W2008494452 @default.
• W3136153275 cites W2020034088 @default.
• W3136153275 cites W2027399451 @default.
• W3136153275 cites W2027863358 @default.
• W3136153275 cites W2031044643 @default.
• W3136153275 cites W2041957959 @default.
• W3136153275 cites W2046771031 @default.
• W3136153275 cites W2053069441 @default.
• W3136153275 cites W2064510700 @default.
• W3136153275 cites W2065434216 @default.
• W3136153275 cites W2070567648 @default.
• W3136153275 cites W2082933786 @default.
• W3136153275 cites W2084186083 @default.
• W3136153275 cites W2092796888 @default.
• W3136153275 cites W2100409705 @default.
• W3136153275 cites W2106782182 @default.
• W3136153275 cites W2114657480 @default.
• W3136153275 cites W2122412604 @default.
• W3136153275 cites W2129623370 @default.
• W3136153275 cites W2131304172 @default.
• W3136153275 cites W2142312775 @default.
• W3136153275 cites W2143523567 @default.
• W3136153275 cites W2153746213 @default.
• W3136153275 cites W2175728132 @default.
• W3136153275 cites W2608093278 @default.
• W3136153275 cites W2759444489 @default.
• W3136153275 cites W2781944731 @default.
• W3136153275 cites W2797309423 @default.
• W3136153275 cites W2910806811 @default.
• W3136153275 cites W2913440788 @default.
• W3136153275 cites W2913665794 @default.
• W3136153275 cites W2945173342 @default.
• W3136153275 cites W2963208179 @default.
• W3136153275 cites W3004856918 @default.
• W3136153275 cites W3043703771 @default.
• W3136153275 cites W3072109384 @default.
• W3136153275 cites W3095854806 @default.
• W3136153275 doi "https://doi.org/10.3390/life11040269" @default.
• W3136153275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8064084" @default.
• W3136153275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33805080" @default.
• W3136153275 hasPublicationYear "2021" @default.
• W3136153275 type Work @default.
• W3136153275 sameAs 3136153275 @default.
• W3136153275 citedByCount "6" @default.
• W3136153275 countsByYear W31361532752021 @default.
• W3136153275 countsByYear W31361532752022 @default.
• W3136153275 countsByYear W31361532752023 @default.
• W3136153275 crossrefType "journal-article" @default.
• W3136153275 hasAuthorship W3136153275A5002843682 @default.
• W3136153275 hasAuthorship W3136153275A5006080186 @default.
• W3136153275 hasAuthorship W3136153275A5040122370 @default.
• W3136153275 hasAuthorship W3136153275A5044921528 @default.
• W3136153275 hasAuthorship W3136153275A5053549188 @default.
• W3136153275 hasAuthorship W3136153275A5059562009 @default.
• W3136153275 hasAuthorship W3136153275A5067045121 @default.
• W3136153275 hasAuthorship W3136153275A5067776208 @default.
• W3136153275 hasAuthorship W3136153275A5088848441 @default.
• W3136153275 hasBestOaLocation W31361532751 @default.
• W3136153275 hasConcept C121608353 @default.
• W3136153275 hasConcept C126322002 @default.
• W3136153275 hasConcept C147483822 @default.
• W3136153275 hasConcept C1491633281 @default.
• W3136153275 hasConcept C154317977 @default.
• W3136153275 hasConcept C19317047 @default.
• W3136153275 hasConcept C202751555 @default.
• W3136153275 hasConcept C203014093 @default.
• W3136153275 hasConcept C204232928 @default.
• W3136153275 hasConcept C2776090121 @default.
• W3136153275 hasConcept C2777658100 @default.
• W3136153275 hasConcept C2777701055 @default.
• W3136153275 hasConcept C2781230642 @default.
• W3136153275 hasConcept C3875195 @default.
• W3136153275 hasConcept C502942594 @default.
• W3136153275 hasConcept C54355233 @default.
• W3136153275 hasConcept C553184892 @default.
• W3136153275 hasConcept C55493867 @default.
• W3136153275 hasConcept C71924100 @default.
• W3136153275 hasConcept C86803240 @default.
• W3136153275 hasConcept C8891405 @default.
• W3136153275 hasConceptScore W3136153275C121608353 @default.

• next